MedPath

Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

Not Applicable
Completed
Conditions
Visual Acuity
Interventions
Device: JJVC Investigational Multifocal Toric Contact Lens manufactured in Senofilcon A (C3) material with UV blocker / HEV filter
Registration Number
NCT06377488
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

This will be an open-label, 3-visit, single-arm, dispensing clinical trial to evaluate visual acuity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
176
Inclusion Criteria

Potential subjects must satisfy all of the following criteria to be enrolled in the study:

  1. Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  2. Appear able and willing to adhere to the instructions set forth in this clinical protocol.
  3. Be at least 40 and not more than 70 years of age at the time of screening.
  4. Own a wearable pair of spectacles if required for their distance vision.
  5. Be an adapted soft contact lens wearer in both eyes (i.e. worn lenses for at least 8 hours per day at least two days per week for the past 4 weeks).
  6. Be already wearing a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".
  7. The subject's distance spherical component of their refraction must be in the range of either -1.25 D to -3.75 D, or +1.25 D to +4.25 D.
  8. The subject's refractive cylinder must be in the range of -1.00 D to -1.75 D in each eye, with the cylinder axes in the range of either 90°±15° or 180°±15°.
  9. The subject's ADD power must be in the range of +0.75 D to +2.50 D in each eye.
  10. The subject must have best corrected distance visual acuity of 20/20-3 or better in each eye.
Exclusion Criteria

Potential subjects who meet any of the following criteria will be excluded from participating in the study:

The subject must not:

  1. Be currently pregnant or lactating.
  2. By self-report, have any systemic disease (e.g. Sjögren's Syndrome), allergies, infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis), or other diseases, which are known to interfere with contact lens wear and/or participation in the study.
  3. Use systemic medications that may interfere with contact lens wear or cause blurred vision. See Section 9.1 for additional details regarding excluded systemic medications.
  4. Currently use ocular medication (with the exception of rewetting drops).
  5. Have any known hypersensitivity or allergic reaction to single use preservative free rewetting drops or sodium fluorescein.
  6. Have had any previous, or have any planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, cataract surgery, retinal surgery, etc.).
  7. Have had previous eyelid injuries, surgeries or procedures which are known to have caused abnormal eyelid position or movement, by self-report.
  8. Have participated in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.
  9. Be an employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
  10. Have a history of amblyopia or strabismus, by self-report.
  11. Have a history of herpetic keratitis, by self-report.
  12. Have ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion.
  13. Have any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA scale.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test ArmJJVC Investigational Multifocal Toric Contact Lens manufactured in Senofilcon A (C3) material with UV blocker / HEV filterEligible subjects who are habitual soft contact lens wearers will be fit with the TEST lens in both eyes, to wear the lens for a minimum of 6 hours a day, every day, between visits for approximately 2 weeks.
Primary Outcome Measures
NameTimeMethod
Rotational Stabilityat least 15-minutes after lens insertion at fitting visit

Rotational stability with blink will be assessed at least 15 minutes after lens insertion at the dispensing visit (Visit 1). Rotational stability is amount of observed rotational movement of the lens' scribe markings in degrees that occurs while blinking in primary gaze.

High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuities at distance 4mat 2-week follow-up

Binocular visual acuity at the 2-week follow-up with the optimized lens pair using high contrast letters in high luminance (120 - 200 cd/m2) and bright illuminance (\>400 lux) conditions will be measured at distance (4 meters) using ETDRS Charts .

High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuities at intermediate distance 64cmat 2-week follow-up

Binocular visual acuity at the 2-week follow-up with the optimized lens pair using high contrast letters in high luminance (225 - 275 cd/m2) and bright illuminance (\>400 lux) conditions will be measured at intermediate distance (64 centimeters) using reduced Guillon-Poling charts.

High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuities at near distance 40cmat 2-week follow-up

Binocular visual acuity at the 2-week follow-up with the optimized lens pair using high contrast letters in high luminance (225 - 275 cd/m2) and bright illuminance (\>400 lux) conditions will be measured at near distance (40 centimeters) using reduced Guillon-Poling charts.

Subjective Vision CLUE Scoresat 2-week follow-up

Subjective vision scores will be assessed using the Contact Lens User Experience (CLUE) questionnaire at the 2-week follow-up in the optimized lens pair. CLUE is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE™ scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Absolute Rotation Errorat least 15-minutes after lens insertion at fitting visit

Absolute rotation error will be assessed at least 15 minutes after lens insertion at the dispensing visit (Visit 1). Absolute rotation error is quantified by the absolute value of mis-location of the lens' scribe markings in degrees relative to a vertical reference line.

Incidence of Unacceptable Lens Fitup to 2-week follow-up

Incidence (percentage) of eyes with unacceptable fitting will be measured at any time during the study. Lens fit is defined as "unacceptable" if any one of the following criteria is met:

* limbal exposure at primary gaze or with extreme eye movement;

* edge lift;

* excessive movement in primary gaze;

* insufficient movement in all three of the following conditions: primary gaze, up gaze, and push up test.

Slit Lamp Findingsup to 2-week follow-up

Slit Lamp Findings will be assessed for each subject eye at all study visits (scheduled and unscheduled). SLFs will be evaluated and classified using the FDA Grading scale rating from 0 to 4, where Grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e., Grade 1=trace, Grade 2=mild, Grade 3=moderate and Grade 4=severe). Eyes with multiple SL findings of Grade≥3 at different timepoint during the visit, or with different grade level over time, will be counted only once.

Secondary Outcome Measures
NameTimeMethod
Subjective Handling Scoresat 2-week follow-up

Subjective Handling Scores will be assessed using the CLUE questionnaire at the 2-week follow-up. CLUE is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE™ scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Subjective Comfort Scoresat 2-week follow-up

Subjective Comfort Scores will be assessed using the CLUE questionnaire at the 2-week follow-up. CLUE is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE™ scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Subjective Vision Scoresat 2-week follow-up

Subjective Vision Scores will be assessed using the CLUE questionnaire at the 2-week follow-up. CLUE is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE™ scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Lens Fit Successup to 1-week follow-up

Lens Fit Success is the number of lenses needed to fit (optimize) the subject's vision. The number of lenses needed is determined using lens selection data from both Visit 1 and Visit 2 .

Trial Locations

Locations (15)

Dr. James Weber & Associates, PA - City Square Blvd

🇺🇸

Jacksonville, Florida, United States

Stam & Associates Eye Care

🇺🇸

Jacksonville, Florida, United States

Omega Vision Center

🇺🇸

Longwood, Florida, United States

Maitland Vision Center - North Orlando Ave

🇺🇸

Maitland, Florida, United States

Mid-State Eye

🇺🇸

Clinton, Illinois, United States

Kannarr Eye Care

🇺🇸

Pittsburg, Kansas, United States

Birmingham Vision Care

🇺🇸

Bloomfield Hills, Michigan, United States

Center for Ophthalmic and Vision Research/Eye Associates of New York

🇺🇸

Manhattan, New York, United States

Sacco Eye Group

🇺🇸

Vestal, New York, United States

ProCare Vision Centers

🇺🇸

Granville, Ohio, United States

Scroll for more (5 remaining)
Dr. James Weber & Associates, PA - City Square Blvd
🇺🇸Jacksonville, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath